Number of employees
14
Annual revenue
$1227000
PolyMedix is the leader in developing biomimetics - novel small molecule, oligomer and polymer protein-mimetic drugs for membrane protein and protein:protein targets. PolyMedix has a proven computational technology platform which was used to develop its first program: a line of unique anti-infective drugs for which bacterial resistance is highly unlikely to develop.